Stay updated with breaking news from Brian Malkin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
![[Event] 20th Paragraph IV Disputes - April 25th - 26th, New York, NY | American Conference Institute (ACI) - Vimarsana News](https://jdsupra-static.s3.amazonaws.com/profile-images/hr.15935_2658.jpg)
Hosted by American Conference Institute, the 20th Annual Paragraph IV Disputes & the 40th Anniversary of the Hatch-Waxman Act returns for another exciting year with curated programming...
Brian J. Malkin is a biotech attorney at McDermott Will and Emery in their Washington, D.C. firm. Brian Malkin counsels pharmaceutical and biologic clients on Food and Drug Administration FDA regulatory matters & Intellectual Property IP law & patent litigation.
Brian J. Malkin is a biotech attorney at McDermott Will and Emery in their Washington, D.C. firm. Brian Malkin counsels pharmaceutical and biologic clients on Food and Drug Administration FDA regulatory matters & Intellectual Property IP law & patent litigation.
Voters on Tuesday will have the chance to impact the Allegheny County Common Pleas Court’s future as nine seats are up for election. Thirty-nine candidates are vying for 10-year positions on the bench. Judges earn $189,794. Although there is a large slate of candidates this year, it’s not even close
10:00 – 11:00 am 2020 was a year like no other as the annual biopharma M&A total fell to the lowest level since EY began publishing its annual M&A Firepower report in 2013. In the first half of the year, the specter of COVID-19 deterred deals; as economies started to reopen, persistently high valuations were another reason many buyers remained on the fence. In the midst of such uncertainty, an innovation narrative emerged, with growing evidence of the power of new technologies, from antibody drug conjugates in oncology to RNA-based vaccines. These new innovations sparked many of 2020’s mo...